← Back to Search

Shared Decision-Making Aid for Lung Cancer

N/A

Recruiting

Led By Konstantinos Leventakos, M.D., Ph.D.

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Non-small cell lung cancer (NSCLC) stage > 1B

Adult patients (>= 18 years of age)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (immediately following appointment); 2 weeks post appointment

Awards & highlights

Study Summary

This trial tests if using a shared decision-making tool in lung cancer care improves patient satisfaction and decision-making.

Who is the study for?

This trial is for adult patients (18+) with non-small cell lung cancer stage >1B who are eligible for adjuvant treatment and can give informed consent. It's open to those at Mayo Clinic in Rochester, including various clinicians. Patients with dementia or severe hearing/vision impairments cannot participate.Check my eligibility

What is being tested?

The study tests a shared decision-making tool used during clinical visits against standard care, aiming to improve the quality of decisions made by lung cancer patients regarding their treatment options.See study design

What are the potential side effects?

Since this trial involves communication tools rather than medical treatments, there are no direct physical side effects; however, participants may experience emotional or psychological impacts from discussing their condition and treatment choices.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My lung cancer is stage 2 or higher.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (immediately following appointment); 2 weeks post appointment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (immediately following appointment); 2 weeks post appointment

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (immediately following appointment); 2 weeks post appointment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Degree of involvement of patients by the clinician in the shared decision making

Effectiveness of the intervention on implementing shared decision making

Provider satisfaction with NSCLC choice conversation aid

Other outcome measures

Decisional conflict scale (DCS)

Knowledge transfer

Patient satisfaction

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm II (standard of care, conversation aid)Experimental Treatment5 Interventions

Patients attend a standard of care visit with the use of the shared decision-making conversation tool by the clinician on study.

Group II: Arm I (standard of care)Active Control4 Interventions

Patients attend a standard of care visit with their clinician on study.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,216 Previous Clinical Trials

3,767,388 Total Patients Enrolled

Konstantinos Leventakos, M.D., Ph.D.Principal InvestigatorMayo Clinic in Rochester

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants currently being accepted for this clinical trial?

"The information hosted on clinicaltrials.gov confirms that this trial is no longer recruiting, as the last edit was made on November 14th 2023. Despite being inactive, there are over two thousand other studies actively seeking candidates at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer

2023. "A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06122064.